Literature DB >> 34955494

Beneficial Effects of Supplementation on Endothelial Function: What Mechanisms?

Yukihito Higashi1,2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34955494      PMCID: PMC9444803          DOI: 10.5551/jat.ED189

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.394


× No keyword cloud information.
Recently, much attention has been given to supplementation, and supplements are now used worldwide. In western countries, focusing on auxiliary effects on nutritional and physiological functions, vitamins, minerals, and herbs are treated as “dietary supplements” and “food supplements.” Some supplements were authorized as health function foods by the Ministry of Health, Labour and Welfare in Japan before their authorization in other countries. However, due to the wide distribution of foods, including supplementation, standardization of supplementation and international unification of display are required. The function of supplementation should be scientifically revealed at the molecular level. In addition, it is clinically important to determine whether supplementation prevents the onset of diabetes, hypertension, cardiovascular disease, and cancer, and whether it has anti-aging effects for the establishment of evidence-based supplementation. From the viewpoint of the significance of supplementation, methods for evaluating the biological regulation functions and clinical evidence of supplementation are strongly required. In a clinical setting, the assessment of endothelial function is established as a surrogate marker for the degree of atherosclerosis, evaluation of therapy for atherosclerosis, and prediction of cardiovascular events . Endothelial dysfunction is the initial step in the pathogenesis of atherosclerosis, leading to the development and maintenance of atherosclerosis, which results in cardiovascular and cerebrovascular outcomes . It is well known that the degree of endothelial dysfunction is a marker of future cardiovascular events in patients with hypertension, diabetes mellitus, coronary artery disease, and peripheral arterial disease . Thus, it is important to select appropriate interventions for the prevention of endothelial dysfunction in patients with atherosclerosis or augmentation of endothelial function even in healthy subjects. Supplementation therapy is one of the interventions for beneficial effects on endothelial function. Several investigators have shown that supplementation, including L-arginine (a substrate of nitric oxide [NO]), tetrahydrobiopterine (a cofactor of NO), antioxidants vitamin C, and other polyphenols with antioxidant properties, such as red wine, chocolate, coffee, tea, fruits, and vegetables, improves or augments endothelium-dependent vasodilation in patients with cardiovascular disease and healthy subjects . In this issue, Fujisue, et al. reported that the administration of royal jelly, a substance selected by honeybees at 690 mg per day for 4 weeks, increased reactive hyperemia index as an index of endothelial function in 100 healthy subjects using a double-blinded, randomized placebo-controlled study design, suggesting royal jelly-induced augmentation of endothelial function. It is thought that the augmentative effects of royal jelly on endothelial function are due to its muscarine receptor agonist effect that activates the endothelial NO synthase (eNOS)/NO/cGMP pathway, enhancement of insulin signaling that activates the eNOS)/NO/cGMP pathway, and inhibition of angiotensin-converting enzyme activity, resulting in an increase in NO production. Royal jelly is composed of a mixture of properties, including moisture, protein, sugar, ether extract, ash, vitamins, minerals, and amino acids . Therefore, it is expected that royal jelly inhibits the degradation of NO through the inhibition of reactive oxygen species (ROS), leading to the augmentation of endothelial function. A balance between released NO and ambient levels of ROS also plays a critical role in the maintenance of endothelial function. Endothelial dysfunction is, at least in part, due to the inactivation of NO by ROS. We have shown that one mechanism of endothelial dysfunction is an increase in ROS in patients with renovascular hypertension, who are ideal models of excess angiotensin II and angiotensin II-related increase in ROS and oxidative stress . Measurement of NO or oxidative stress markers, 8-hydroxy-2’-deoxyguanosin, isoprostanes, and malondialdehyde-modified low-density lipoprotein, and assessment of the antioxidant system, such as superoxide dismutase, glutathione peroxidase, and catalase, would enable a more specific conclusion concerning the role of administration of royal jelly in NO bioavailability and endothelial function to be drawn. Future studies are needed to determine the precise mechanisms by which supplementation therapy, including royal jelly, improves endothelial function in patients with atherosclerosis or augments endothelial function in healthy subjects . NO indicates nitric oxide. ROS inducates reactive oxygen species.

Conflict of Interest

No conflict of interest.
  10 in total

1.  Prognostic significance of endothelial dysfunction in hypertensive patients.

Authors:  F Perticone; R Ceravolo; A Pujia; G Ventura; S Iacopino; A Scozzafava; A Ferraro; M Chello; P Mastroroberto; P Verdecchia; G Schillaci
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals.

Authors:  Yukihito Higashi; Shota Sasaki; Keigo Nakagawa; Yukihiro Fukuda; Hideo Matsuura; Tetsuya Oshima; Kazuaki Chayama
Journal:  Am J Hypertens       Date:  2002-04       Impact factor: 2.689

Review 4.  Exercise and endothelial function: role of endothelium-derived nitric oxide and oxidative stress in healthy subjects and hypertensive patients.

Authors:  Yukihito Higashi; Masao Yoshizumi
Journal:  Pharmacol Ther       Date:  2004-04       Impact factor: 12.310

5.  Endothelial function and oxidative stress in renovascular hypertension.

Authors:  Yukihito Higashi; Shota Sasaki; Keigo Nakagawa; Hideo Matsuura; Tetsuya Oshima; Kazuaki Chayama
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

6.  Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension.

Authors:  Y Higashi; T Oshima; R Ozono; M Watanabe; H Matsuura; G Kajiyama
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

7.  Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

Authors:  S Taddei; A Virdis; L Ghiadoni; A Magagna; A Salvetti
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690

Review 8.  Endothelial function and oxidative stress in cardiovascular diseases.

Authors:  Yukihito Higashi; Kensuke Noma; Masao Yoshizumi; Yasuki Kihara
Journal:  Circ J       Date:  2009-02-04       Impact factor: 2.993

9.  A Randomized, Double-Blind Comparison Study of Royal Jelly to Augment Vascular Endothelial Function in Healthy Volunteers.

Authors:  Koichiro Fujisue; Eiichiro Yamamoto; Daisuke Sueta; Yuichiro Arima; Kyoko Hirakawa; Noriaki Tabata; Masanobu Ishii; Miwa Ito; Kenshi Yamanaga; Shinsuke Hanatani; Tadashi Hoshiyama; Hisanori Kanazawa; Seiji Takashio; Satoshi Araki; Hiroki Usuku; Taishi Nakamura; Hirofumi Soejima; Koichi Kaikita; Hiroaki Kawano; Kenichi Matsushita; Kenichi Tsujita
Journal:  J Atheroscler Thromb       Date:  2021-09-28       Impact factor: 4.394

10.  Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD-J (Flow-Mediated Dilation Japan) Study A.

Authors:  Tatsuya Maruhashi; Junko Soga; Noritaka Fujimura; Naomi Idei; Shinsuke Mikami; Yumiko Iwamoto; Akimichi Iwamoto; Masato Kajikawa; Takeshi Matsumoto; Nozomu Oda; Shinji Kishimoto; Shogo Matsui; Haruki Hashimoto; Yoshiki Aibara; Farina Mohamad Yusoff; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; Ayumu Nakashima; Chikara Goto; Hirofumi Tomiyama; Bonpei Takase; Takahide Kohro; Toru Suzuki; Tomoko Ishizu; Shinichiro Ueda; Tsutomu Yamazaki; Tomoo Furumoto; Kazuomi Kario; Teruo Inoue; Shinji Koba; Kentaro Watanabe; Yasuhiko Takemoto; Takuzo Hano; Masataka Sata; Yutaka Ishibashi; Koichi Node; Koji Maemura; Yusuke Ohya; Taiji Furukawa; Hiroshi Ito; Hisao Ikeda; Akira Yamashina; Yukihito Higashi
Journal:  J Am Heart Assoc       Date:  2018-07-12       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.